Search | Pikumil

Priti Mrfr added blog Health
2026-08-31 16:16:32 -

Rapid Sterility Testing Market – Modernizing Pharmaceutical Microbiology Labs
Market Overview The rapid sterility testing market is modernizing pharmaceutical microbiology laboratories that have relied on century-old compendial methods with limited innovation. As pharmaceutical portfolios shift toward complex biologics and personalized medicines, microbiology labs face pressure to deliver faster, more reliable sterility data while maintaining regulatory compliance. The...

0 Comments 0 Shares 107 Views 0 Reviews

Please log in to like, share and comment!
Priti Mrfr added blog Health
2026-09-03 09:17:47 -

Rapid Sterility Testing Market – Regulatory Pressure Accelerating Faster Results
Market Overview The Rapid Sterility Testing Market is developing rapidly because pharmaceutical and medical-device companies face increasing pressure to demonstrate product safety and shorten manufacturing timelines. Sterility testing is a critical quality-control activity, but conventional approaches may delay product release because results can take an extended period to become available. The...

0 Comments 0 Shares 66 Views 0 Reviews

Please log in to like, share and comment!
Shiv Mehara added blog Other
2025-12-04 11:14:45 -

Bioburden Testing Market - 2024 Current Analysis by Market Share Upto 2032
Introspective Market Research, a leading authority in life science and regulatory intelligence, today released a comprehensive report on the Global Bioburden Testing Market. The study reveals that the market, valued at USD 1.46 Billion in 2023, is poised for robust expansion, projected to reach USD 4.26 Billion by 2032. This significant growth is underpinned by an aggressive Compound Annual...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!
Ajay Sukla added blog Health
2026-04-02 12:40:31 -

Biomonitoring and Bioburden Testing Market to Reach USD 6.2 Billion by 2031 | CAGR 7.2%
According to a newly published market research report by 24LifeSciences, global biomonitoring and bioburden testing market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2031. Biomonitoring involves the measurement of toxic substances in biological specimens, while...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!